Related Experiment Video
Updated: Jun 21, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis
S S L Chew1, N M Kerr, H V Danesh-Meyer
1Department of Ophthalmology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand.
Insights
Giant cell arteritis (GCA) is an immune-mediated vasculitis in older adults, causing inflammation in large arteries. Early recognition of neurological or visual symptoms and prompt corticosteroid treatment are crucial for halting disease progression.
Area of Science:
- Rheumatology
- Immunology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is an immune-mediated vasculitis affecting medium and large arteries in individuals over 50.
- Clinical manifestations range from tissue ischemia due to vascular lesions to systemic inflammatory responses.
- Distinct pathogenesis is proposed: adaptive immunity for vascular lesions and innate immunity for systemic inflammation.
Purpose of the Study:
- To summarize the key aspects of Giant Cell Arteritis.
- To highlight the clinical presentation and underlying immune mechanisms.
- To emphasize the importance of early diagnosis and treatment.
Main Methods:
- Review of existing literature on Giant Cell Arteritis.
- Analysis of clinical manifestations and proposed pathogenetic pathways.
- Emphasis on diagnostic suspicion and therapeutic interventions.
Main Results:
- GCA presents with diverse symptoms, including those from ischemia and systemic inflammation.
- Vascular lesions are linked to adaptive immunity, while systemic inflammation involves innate immunity.
- High index of suspicion is needed for neurological/visual symptoms.
Conclusions:
- Prompt high-dose corticosteroid treatment is invaluable in halting GCA progression.
- Understanding the distinct immune responses is key to managing GCA.
- Early diagnosis and intervention are critical for preventing irreversible damage.
Abstract:
Giant cell arteritis (GCA) is an immune-mediated vasculitis affecting individuals over 50 years of age. It is characterised by granulomatous inflammation that affects medium-sized and large arteries. The wide spectrum of clinical manifestations can be divided into those related to tissue ischemia from vascular lesions and those related to a systemic inflammatory response. The pathogenesis of these groups also appears distinct, with vascular lesion formation thought to be an adaptive immune response, and the systemic inflammatory reaction an innate immune response. Clinical suspicion of GCA must remain especially high in those with neurological or visual symptoms and if warranted, prompt treatment with high-dose corticosteroids is invaluable in halting disease progression.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Chronic Inflammation: Introduction
Rheumatic Heart Disease I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
